Pfizer's coronavirus vaccine could be approved by the October-end - Goldman Sachs

Investment bank Goldman Sachs expects the American pharma giant Pfizer's coronavirus vaccine candidate to get approval by the end of October and Massachusetts-based biotechnology company Moderna's candidate by late November. 

Key quote

Pfizer could deliver 100 million doses by the end of 2020 and 1.2 billion doses in 2021. 

Analysts at Morgan Stanley expect Moderna and Pfizer to produce trial results by mid-November.